Peltola H - Search Results

1

Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme.

Peltola H, Jokinen S, Paunio M, Hovi T, Davidkin I. Peltola H, et al. Lancet Infect Dis. 2008 Dec;8(12):796-803. doi: 10.1016/S1473-3099(08)70282-2. Lancet Infect Dis. 2008. PMID: 19022194 Review.

2

Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella.

Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. Davidkin I, et al. Among authors: peltola h. J Infect Dis. 2005 Mar 1;191(5):719-23. doi: 10.1086/427338. Epub 2005 Jan 19. J Infect Dis. 2005. PMID: 15688285

3

Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines.

Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Peltola H, et al. Clin Infect Dis. 2007 Aug 15;45(4):459-66. doi: 10.1086/520028. Epub 2007 Jul 10. Clin Infect Dis. 2007. PMID: 17638194

4

Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.

Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Davidkin I, et al. Among authors: peltola h. J Infect Dis. 2008 Apr 1;197(7):950-6. doi: 10.1086/528993. J Infect Dis. 2008. PMID: 18419470

5

MMR vaccination and disease elimination: the Finnish experience.

Davidkin I, Kontio M, Paunio M, Peltola H. Davidkin I, et al. Among authors: peltola h. Expert Rev Vaccines. 2010 Sep;9(9):1045-53. doi: 10.1586/erv.10.99. Expert Rev Vaccines. 2010. PMID: 20822347 Free article. Review.

6

Waning antibody levels and avidity: implications for MMR vaccine-induced protection.

Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Kontio M, et al. Among authors: peltola h. J Infect Dis. 2012 Nov 15;206(10):1542-8. doi: 10.1093/infdis/jis568. Epub 2012 Sep 10. J Infect Dis. 2012. PMID: 22966129

7

Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland.

Paunio M, Virtanen M, Peltola H, Cantell K, Paunio P, Valle M, Karanko V, Heinonen OP. Paunio M, et al. Among authors: peltola h. Am J Epidemiol. 1991 Jun 1;133(11):1152-60. doi: 10.1093/oxfordjournals.aje.a115827. Am J Epidemiol. 1991. PMID: 2035518

8

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. Peltola H, et al. N Engl J Med. 1994 Nov 24;331(21):1397-402. doi: 10.1056/NEJM199411243312101. N Engl J Med. 1994. PMID: 7969278 Free article.

9

Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children.

Davidkin I, Valle M, Peltola H, Hovi T, Paunio M, Roivainen M, Linnavuori K, Jokinen S, Leinikki P. Davidkin I, et al. Among authors: peltola h. J Infect Dis. 1998 Dec;178(6):1567-70. doi: 10.1086/314513. J Infect Dis. 1998. PMID: 9815205

10

Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.

Davidkin I, Peltola H, Leinikki P, Valle M. Davidkin I, et al. Among authors: peltola h. Vaccine. 2000 Jul 15;18(27):3106-12. doi: 10.1016/s0264-410x(00)00139-0. Vaccine. 2000. PMID: 10856790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters